Angiodynamics Inc (ANGO) - News Archive

Showing 9 of 9 results.

LATHAM, N.Y. AngioDynamics, Inc. (NASDAQ ANGO), a prominent medical technology company committed to enha...

AngioDynamics NanoKnife System Recognised in TIME’s 2025 Best Inventions List LATHAM, N.Y. AngioDynamics, Inc. (NASDAQ: ANGO), a prominent medical technology company committed to enhancing vascular health and cancer tre...

Oct 13, 2025 • Medical Equipment & Supplies Industry Business Update NASDAQ

AngioDynamics Innovates & Excels FDA Greenlights NanoKnife for Prostate Cancer Amidst Financial Accolades,

AngioDynamics Triumphs: FDA Clears Innovative NanoKnife System for Prostate Treatment Amid Financial Prowess In a significant stride for medical innovation, AngioDynamics, Inc. (NASDAQ: ANGO), a dynamic player in the me...

Dec 31, 2024 • Medical Equipment & Supplies Industry Business Update NASDAQOppenheimer Oppenheimer S Clemmer

AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18 System in Treatment of Pulmonary Embolism an...

Breaking Ground in Pulmonary Embolism Treatment: AngioDynamics Initiates Pioneering RECOVER-AV Clinical Trial Latham, N.Y. AngioDynamics, Inc. (NASDAQ: ANGO), a leading figure in transformative medical technology focuse...

Sep 20, 2024 • Medical Equipment & Supplies Industry Business Update NASDAQ Inc Inc Med Tech Fourth Quarter Earnings Ca

AngioDynamics Unveils Pioneering Clinical Endeavor for Thrombotic Treatment Amidst Financial Setbacks

In the ever-evolving realm of medical technology, where innovation coalesces with the poignant demands of therapeutic efficacy, AngioDynamics, Inc. a venerable entity listed on the NASDAQ under the ticker ANGO, has rece...

Sep 19, 2024 • Medical Equipment & Supplies Industry Business Update NASDAQ Inc Inc Med Tech Fourth Quarter Earnings Ca

AngioDynamics Secures CE Mark for Auryon Atherectomy System, Advancing Treatment for Peripheral Artery Disease in Eur...

AngioDynamics, Inc. a prominent medical technology company renowned for its innovations in vascular health, announced on Monday that it has received CE Mark approval in Europe for its Auryon Atherectomy System. This sys...

Sep 3, 2024 • Medical Equipment & Supplies Industry Business Update NASDAQ Inc Inc Med Tech Fourth Quarter Earnings Ca

AngioDynamics’ AlphaVac F18 System Achieves CE Mark Approval, Revamping Pulmonary Embolism Treatment with Promising APEX-AV Trial Outcomes

LATHAM, N.Y. AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company, has announced a significant milestone in its ongoing efforts to advance the treatment of vascular diseases and im...

May 22, 2024 • Medical Equipment & Supplies Industry Business Update NASDAQ

AngioDynamics Secures CE Mark Approval for AlphaVac F18 System in Europe, Augmenting Pulmonary Embolism Treatment

LATHAM, N.Y. AngioDynamics, Inc. (NASDAQ: ANGO), a pioneering medical technology company committed to transforming vascular health, broadening cancer treatment options, and enhancing patient quality of life, has proudly...

May 21, 2024 • Medical Equipment & Supplies Industry Business Update NASDAQ

AngioDynamics' AlphaVac F18 System Shows Promise in Treating Pulmonary Embolism: Evolving Clot Removal with Minimally Invasive Technology

Pulmonary embolism (PE) is a serious medical condition characterized by a sudden blockage in one of the arteries in the lungs. If left untreated, PE can be life-threatening. Current treatment options for PE include medi...

May 6, 2024 • Medical Equipment & Supplies Industry Business Update NASDAQ

AngioDynamics Expands Horizons: Completes $45 Million Sale to Spectrum Vascular, Achieves Milestone in Groundbreaking APEX-AV Study

AngioDynamics Announces $45 Million Sale of PICC and Midline Product Portfolios to Spectrum Vascular, Completes Patient Enrollment in APEX-AV StudyIn a significant strategic move, AngioDynamics, Inc. (NASDAQ: ANGO), an...

Feb 15, 2024 • Medical Equipment & Supplies Industry Product Service News NASDAQ